Governance Logic of the Dilemma in Medication Assurance of Rare Disease Under the Framework of"Cross-Border Enpowerment"——Taking the Neurofibromatosis Type 1 as a Case
In recent years,the medication assurance of rare diseases in China has been significantly improved,with some diseases transitioning from"no drug supply"to"including drugs into basic medical insurance list".The study takes the neurofibroma type 1 as a case study,constructing an explanatory framework of"cross-border empowerment"in order to analyze the governance logic of breaking through the dilemma.This study found that in the field of market failures such as rare disease drugs,the government empowers market players by enacting favorable public policies,which effectively motivates them to take the initiative,while the market empowers other governance bodies and facilitates the formation of frequent interaction behaviors among multiple players across the border.The results of the interaction positively empower market players again,which to some extent effectively compensates for the market failures,and overcomes the dilemmas of medication assurance of rare diseases.
万方数据
